Literature DB >> 11473643

Compensated heart failure predisposes to outer medullary tubular injury: studies in rats.

M Goldfarb1, Z Abassi, S Rosen, A Shina, M Brezis, S N Heyman.   

Abstract

BACKGROUND: Heart failure (HF) is considered a putative factor predisposing to acute renal failure (ARF). Since outer medullary hypoxic injury may play an important role in the pathogenesis of acute tubular necrosis, we explored the impact of experimental HF on the propensity to develop ARF with hypoxic medullary injury following the inhibition of prostaglandin and nitric oxide synthesis.
METHODS: Compensated, high-output HF was induced in Sprague-Dawley rats by aorto-caval fistula. At the eighth to ninth postoperative day, the rats were injected with indomethacin and N(omega) nitro-L-arginine methyl ester (L-NAME; ARF protocol) and were sacrificed 24 hours later for morphologic evaluation.
RESULTS: Kidney function comparably declined in HF-ARF rats and in control sham operated animals (CTR-ARF). Nevertheless, outer medullary hypoxic damage with medullary thick ascending limb (mTAL) necrosis occurred almost exclusively in the HF-ARF group (11 +/- 4% vs. 0.2 +/- 0.2% of tubules in CTR-ARF, P < 0.03). In a third group of HF animals subjected to vehicles only (HF-Nil), kidney function was preserved and renal morphology remained intact. Papillary-tip necrosis was consistently found in all animals subjected to indomethacin and L-NAME, irrespective of preconditioning. Morphometric evaluation disclosed that HF was not associated with mTAL hypertrophy.
CONCLUSIONS: Incipient HF predisposes to hypoxic outer medullary injury, probably reflecting the impact of regional vasoconstrictive stimuli rather than tubular hypertrophy when protective local vasodilating mechanisms are hampered. The presence and extent of outer medullary hypoxic damage cannot be predicted from the functional derangement, which in the experimental settings may also represent prerenal azotemia or papillary damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473643     DOI: 10.1046/j.1523-1755.2001.060002607.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Unique Transcriptional Programs Identify Subtypes of AKI.

Authors:  Katherine Xu; Paul Rosenstiel; Neal Paragas; Christian Hinze; Xiaobo Gao; Tian Huai Shen; Max Werth; Catherine Forster; Rong Deng; Efrat Bruck; Roger W Boles; Alexandra Tornato; Tejashree Gopal; Madison Jones; Justin Konig; Jacob Stauber; Vivette D'Agati; Hediye Erdjument-Bromage; Subodh Saggi; Gebhard Wagener; Kai M Schmidt-Ott; Nicholas Tatonetti; Paul Tempst; Juan A Oliver; Paolo Guarnieri; Jonathan Barasch
Journal:  J Am Soc Nephrol       Date:  2016-12-27       Impact factor: 10.121

2.  Prognosis in patients with congestive heart failure and subacute renal failure treated with hemodialysis.

Authors:  Gregor Lindner; Edith Doberer; Andreas Vychytil; Gürkan Sengölge; Samo Wakounig; Deddo Moertl; Walter H Hörl; Wilfred Druml
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling.

Authors:  Tomoko Ichiki; Brenda K Huntley; Gail J Harty; S Jeson Sangaralingham; John C Burnett
Journal:  Physiol Rep       Date:  2017-05-15

4.  Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure.

Authors:  Mari Katsumata; Nobuhito Hirawa; Koichiro Sumida; Minako Kagimoto; Yosuke Ehara; Yuki Okuyama; Megumi Fujita; Akira Fujiwara; Mayumi Kobayashi; Yusuke Kobayashi; Yuichiro Yamamoto; Sanae Saka; Keisuke Yatsu; Tetsuya Fujikawa; Yoshiyuki Toya; Gen Yasuda; Kouichi Tamura; Satoshi Umemura
Journal:  Clin Exp Nephrol       Date:  2017-02-11       Impact factor: 2.801

5.  AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats.

Authors:  Vojtech Kratky; Zdenka Vanourkova; Matus Sykora; Barbara Szeiffova Bacova; Zdenka Hruskova; Sona Kikerlova; Zuzana Huskova; Libor Kopkan
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

6.  Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker.

Authors:  Lior Lupu; Keren-Lee Rozenfeld; David Zahler; Samuel Morgan; Ilan Merdler; Moshe Shtark; Ilana Goldiner; Shmuel Banai; Yacov Shacham
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

7.  Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study).

Authors:  Milos Brankovic; K Martijn Akkerhuis; Ewout J Hoorn; Nick van Boven; Jan C van den Berge; Alina Constantinescu; Jasper Brugts; Jan van Ramshorst; Tjeerd Germans; Hans Hillege; Eric Boersma; Victor Umans; Isabella Kardys
Journal:  Clin Cardiol       Date:  2020-04-16       Impact factor: 2.882

8.  Inhibition of inflammation using diacerein markedly improved renal function in endotoxemic acute kidney injured mice.

Authors:  Guangzhe Yu; Qian Liu; Xuening Dong; Kaihong Tang; Bohui Li; Chunmei Liu; Wenzheng Zhang; Yiduo Wang; Yingyu Jin
Journal:  Cell Mol Biol Lett       Date:  2018-08-16       Impact factor: 5.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.